Deal Snapshot
ASKBIO ACQUIRES ASSETS FROM ROVERMED BIOSCIENCES
Wednesday 18 September 2019

US-based Adeno-Associated Virus gene therapy platform company Asklepios BioPharmaceutical, Inc. (AskBio) has acquired the technology assets of RoverMed BioSciences, the company said.
RoverMed developed nanotechnology cargo delivery of therapeutics into the nucleus of diseased cells without affecting healthy cells. Under the terms of the agreement, AskBio will integrate the company's technology and assume all assets of RoverMed.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 18/09/2019
Target: RoverMed BioSciences
Country: USA
Sector: Biotechnology
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Asklepios BioPharmaceutical, Inc
Comment:
Terms of the deal were not disclosed

Options